Tag: Valneva
The Valneva laboratory is trying to relaunch itself with its vaccine against chikungunya
Thomas Lingelbach, CEO of Valneva, in Livingston, Scotland, March 28, 2022. ANDY BUCHANAN / AFP At the headquarters of the Franco-Austrian pharmaceutical laboratory Valneva, in Saint-Herblain (Loire-Atlantique), near Nantes, a…
Valneva: an MA application deemed admissible by the EMA – 11/27/2023 at 07:25
(CercleFinance.com) – Valneva announces that the European Medicines Agency (EMA) has deemed admissible its marketing authorization application (MA) for its single-dose vaccine candidate against chikungunya VLA1553. “The chikungunya virus, or…
Valneva: favorable opinion from the EMA for its anti-chikungunya vaccine
(AOF) – Valneva announces today that the European Medicines Agency (EMA) has “carried out a technical validation of the marketing authorization application” for its single-dose vaccine candidate against chikungunya VLA1553…
Valneva: positive immunogenicity data in CHIKV
(CercleFinance.com) – Valneva reports positive pivotal phase III results in adolescents regarding the immunogenicity of its single-injection live attenuated chikungunya virus (CHIKV) vaccine candidate, VLA1553. These pivotal data showed that…
Valneva: Positive immunogenicity data in CHIKV
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Valneva: an analyst aims higher
By Hector Chaunu Published on 09/11/2023 at 11:05 a.m. Photo credit © Valneva (Boursier.com) — Valneva rose 1%…
Valneva: US FDA approves chikungunya vaccine for adults – 10/11/2023 at 08:17
valneva laboratory 1 (photo credit: Valneva Group / ) Valneva announced Friday that the U.S. Food and Drug Administration (FDA) has approved its single-dose chikungunya vaccine for people ages 18…
Abnormal volumes in Paris today: Valneva
During this stock market session on Friday November 10, 2023, particularly high trading volumes were detected on the French market. Today, it is the Valneva share which stands out, with…
Valneva jumps after FDA approval of its chikungunya vaccine – 10/11/2023 at 09:12
(Photo credits: Valneva Group – ) (AOF) – The biggest increase in the SBF 120 index, Valneva jumped 8.31% to 6.83 euros after announcing the FDA approval of its vaccine…
EU to expedite review of Valneva chikungunya vaccine
Published on Oct 25, 2023 at 7:01 p.m. PARIS (Agefi-Dow Jones)–The biotechnology company Valneva announced on Wednesday that it had submitted an authorization request for its chikungunya vaccine to European…
Valneva: will present its research on chikungunya – 10/11/2023 at 6:07 p.m.
(CercleFinance.com) – Valneva announces today that it will make presentations on chikungunya at various leading scientific conferences organized during the fourth quarter of 2023. During IDWeek, the annual meeting of…
Valneva: will present its research on chikungunya
(CercleFinance.com) – Valneva announces today that it will make presentations on chikungunya at various leading scientific conferences organized during the fourth quarter of 2023. During IDWeek, the annual meeting of…